NCT07558252

Brief Summary

There are studies in the literature evaluating the effects of acupressure application in MS patients. In a study; it was shown that acupressure application reduced pain and fatigue. In a study; acupressure was found to reduce fatigue and depression scores. In a study; acupressure was found to improve the patient's physical and cognitive functions and quality of life. In a study; acupressure was found to have positive effects on reducing fatigue in MS patients. In a study acupressure application was found to have significant effects in reducing fatigue. There are no studies evaluating the combined effects of acupressure on fatigue, pain, sleep quality, and quality of life parameters in MS patients. This study is planned to determine the effects of acupressure on fatigue, pain, sleep quality, and quality of life in MS patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P75+ for not_applicable multiple-sclerosis

Timeline
Completed

Started Mar 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

April 7, 2026

Completed
23 days until next milestone

First Posted

Study publicly available on registry

April 30, 2026

Completed
Last Updated

April 30, 2026

Status Verified

April 1, 2026

Enrollment Period

8 months

First QC Date

April 7, 2026

Last Update Submit

April 23, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Fatigue Severity Scale (FSS)

    The FSS is a 9-item scale used to assess the impact of fatigue on daily activities. Each item is rated on a 7-point Likert scale ranging from 1 to 7. The total score is the average of the 9 items. Scores range from 1 to 7, where higher scores indicate greater fatigue severity (worse outcome).

    Baseline, at the end of the 3rd week, and at the end of the 6th week.

Secondary Outcomes (3)

  • Visual Analog Scale (VAS) for Pain

    Baseline, at the end of the 3rd week, and at the end of the 6th week.

  • Pittsburgh Sleep Quality Index (PSQI)

    Baseline, at the end of the 3rd week, and at the end of the 6th week.

  • Multiple Sclerosis Quality of Life-54 (MSQOL-54)

    Baseline, at the end of the 3rd week, and at the end of the 6th week.

Study Arms (3)

intervention

EXPERIMENTAL

intervention

Other: Acupressure

sham

SHAM COMPARATOR

Plasebo

Other: Acupressure

Control

NO INTERVENTION

Control

Interventions

examining pain, fatigue, sleep, and quality of life

interventionsham

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • At least 6 months of confirmed MS diagnosis
  • With RRMS
  • Aged 18 years or older
  • With a pain score of VAS≥3
  • Not having used pain medication in the last 8 hours prior to the acupressure session
  • With a Fatigue Severity Scale score of 4 or higher
  • Without a diagnosis of cancer
  • Without diabetes
  • No neurological disease other than MS
  • Not receiving any other complementary treatment
  • Non-smoker
  • Literate and able to communicate
  • No deformity or lesion in the areas where acupressure will be applied
  • No mental problems that could prevent cooperation with the acupressure application
  • Not taking sedative medication
  • +5 more criteria

You may not qualify if:

  • Patients who did not attend at least 4 sessions
  • Patients who wish to withdraw from the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital of Harran University

Sanliurfa, Şanlıurfa, 63000, Turkey (Türkiye)

Location

Related Links

MeSH Terms

Conditions

Multiple Sclerosis

Interventions

Acupressure

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Therapy, Soft TissueMusculoskeletal ManipulationsComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

April 7, 2026

First Posted

April 30, 2026

Study Start

March 1, 2025

Primary Completion

November 1, 2025

Study Completion

April 1, 2026

Last Updated

April 30, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations